Functional contrast-enhanced CT for evaluation of acute ischemic stroke does not increase the risk of contrast-induced nephropathy. - Wikidata - wikimedia - TriplyDB

Functional contrast-enhanced CT for evaluation of acute ischemic stroke does not increase the risk of contrast-induced nephropathy.

Functional contrast-enhanced CT for evaluation of acute ischemic stroke does not increase the risk of contrast-induced nephropathy.

http://www.wikidata.org/entity/Q33862673

about

The diagnosis of acute mesenteric ischemia: A systematic review and meta-analysis Improved outcome prediction using CT angiography in addition to standard ischemic stroke assessment: results from the STOPStroke study The cost-utility of CT angiography and conventional angiography for people presenting with intracerebral hemorrhage.Does intravenous contrast-enhanced computed tomography cause acute kidney injury? Protocol of a systematic review of the evidence.CT angiography predicts use of tertiary interventional services in acute ischemic stroke patients.Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material.Computed Tomography Angiography in the Assessment of Patients With Stroke/TIA Contrast CT Scans in the Emergency Department Do Not Increase Risk of Adverse Renal Outcomes.Contrast medium-induced nephrotoxicity risk assessment in adult inpatients: a comparison of serum creatinine level- and estimated glomerular filtration rate-based screening methods.Emergency noninvasive angiography for acute intracerebral hemorrhage.Role of cardiac and extracranial vascular CT in the evaluation/management of cerebral ischemia and stroke.Renal dysfunction in stroke patients: a hospital-based cohort study and systematic review.Added value of multimodal computed tomography imaging: analysis of 1994 acute ischaemic strokes.Development of contrast-induced nephropathy in subarachnoid hemorrhage: a single center perspective.Prolonged carotid sinus reflex is a risk factor for contrast-induced nephropathy following carotid artery stenting.Guidelines on the use of iodinated contrast media in patients with kidney disease 2012: digest version : JSN, JRS, and JCS Joint Working Group.Guidelines on the use of iodinated contrast media in patients with kidney disease 2012: digest version. JSN, JRS, and JCS Joint Working Group.Iodixanol versus iopromide in cancer patients: Evidence from a randomized clinical trial.Acute stroke imaging: CT with CT angiography and CT perfusion before management decisions.Computed Tomography Angiography before Intravenous Thrombolysis Does Not Increase the Risk of Renal Dysfunction

P2860

Q27006840-87CF502B-7A2C-4E82-80AF-DD357959A677 Q28732524-946F23CF-B78A-4A51-87C8-225F5DFC76C7 Q35167914-3CFE55E8-AE00-4464-B371-0BBC24E03432 Q35230061-49AFDF2A-BF30-4540-A207-A0C8F5EFC3CC Q35461329-26B5D216-BF89-45C9-A0A3-41C362BE83E9 Q36710941-D756DB45-2CDE-467B-B808-8D6E9DAB3B65 Q37052647-82BFC063-0516-43B9-894C-76FFDD83E324 Q37094719-77B83B80-702C-4B66-8342-5668BE37D585 Q37193034-39FA3C09-5B4E-4290-8410-6308641A0CB0 Q38057668-10DBB4F5-5315-444A-81D5-58977B3FBF92 Q38092043-863333B6-0814-46BF-AEED-D0FD5D25E7BB Q38195344-FD5EBE31-E351-4ED8-8728-AE75B71709D2 Q39228053-A99FADD8-EA30-419F-A81E-E1FF8AC53517 Q43860362-F9B96A55-11A4-40C8-BAD1-E73792F4020B Q44825251-0F355A8A-2A70-43E2-9EAC-FFEC2976A323 Q45043102-8B352150-22D4-4C3C-9EB1-E0AAF866D82D Q45334831-181FDABB-ED64-4793-B3AD-1A86F41AC479 Q48290381-383C3E9E-8CFA-407F-B047-695512823D5D Q48601447-E5DF8BFE-C251-4834-9C63-285E3C62F547 Q58998989-765577EE-3364-4ECD-9169-66BAEB5EE6D7

P2860

Functional contrast-enhanced CT for evaluation of acute ischemic stroke does not increase the risk of contrast-induced nephropathy.

http://www.wikidata.org/entity/Q33862673

description

2009 nî lūn-bûn

@nan

2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Functional contrast-enhanced C ...... contrast-induced nephropathy.

@ast

Functional contrast-enhanced C ...... contrast-induced nephropathy.

@en

type

label

Functional contrast-enhanced C ...... contrast-induced nephropathy.

@ast

Functional contrast-enhanced C ...... contrast-induced nephropathy.

@en

prefLabel

Functional contrast-enhanced C ...... contrast-induced nephropathy.

@ast

Functional contrast-enhanced C ...... contrast-induced nephropathy.

@en

P1433

Q33862673-9FF914A3-593A-43BF-A5E6-886205EEDF60

P1476

Q33862673-AE7ED796-BED7-4540-BB30-1CDE57301679

P2093

Q33862673-07B8EA83-4C4A-4646-B548-95FD4B011C2F

Q33862673-21682DC4-A0A2-4759-9565-9240D59790E5

Q33862673-3198F95A-8B02-43F7-B626-713DC8ED2EEB

Q33862673-75FC7D8F-08AF-41C8-97E3-9DB0FC47F2F7

Q33862673-9515F2B3-EED0-4230-BABF-0194FA1DCBC4

Q33862673-999DFCC2-1540-46C0-84B8-4F9F1E5A07A1

Q33862673-AB3199ED-58C2-48C3-92DB-B03B313E35BA

Q33862673-CA0A0E7A-89F3-4096-BD65-E9C0923BA925

Q33862673-DB702F2E-369A-4554-8D6A-C0B683C67E9A

Q33862673-E21F0BC4-CA64-4729-9E34-90724AAFEF9D

P2860

Q33862673-0140B9C4-9CA4-40A0-9E33-87C258E98175

Q33862673-0AEDE2D8-4238-4EC8-A01E-AA314E9F2F53

Q33862673-228A5900-4BE5-446B-A477-6725E4FCB543

Q33862673-2621BCBF-7E81-4ABB-B84A-A0FB7D6A0F80

Q33862673-3B288D74-C487-4B02-A1A9-EAF454CC23EC

Q33862673-40845BC2-80B3-44C9-BC89-6A0C05DC6714

Q33862673-44D93CBE-2D40-4E54-8110-A2BCF92599D5

Q33862673-7AF3E59B-7DE3-4347-9BC6-A8E5393656E9

Q33862673-9A8B5AA7-0DEA-4F90-ABDF-378843188968

Q33862673-9F318B10-1A86-4F4C-98DA-81C157931615

P304

Q33862673-2CBBE460-81A1-44D0-8996-A628029F6742

P31

Q33862673-ADC78615-A7EB-4073-94F3-349557461543

P356

Q33862673-D1837AE6-385F-4ADB-BB11-285024A4B5CE

P433

Q33862673-31BF202B-28AF-4D18-95D4-139FDFAA0DBB

P478

Q33862673-EC0A5CE5-B1D9-4D76-B016-72F00C0DA2B3

P50

Q33862673-028C3E51-49A0-4011-A906-2D32861BA916

Q33862673-F06B4A73-50E5-44C9-A05F-48C883E34B7A

P577

Q33862673-750E0502-DE48-4B12-A62E-A48DFD5F802A

P698

Q33862673-2463CAB2-8343-4823-8E53-78C086840E1D

P932

Q33862673-C12BA620-1CE4-4432-89EC-0B2C76B13385

P356

P1433

American Journal of Neuroradiology

P1476

Functional contrast-enhanced C ...... f contrast-induced nephropathy

@en

P2093

A B Singhal

http://www.w3.org/2001/XMLSchema#string

E C de Camargo

http://www.w3.org/2001/XMLSchema#string

G S Silva

http://www.w3.org/2001/XMLSchema#string

H Ay

http://www.w3.org/2001/XMLSchema#string

K L Furie

http://www.w3.org/2001/XMLSchema#string

M Ebril

http://www.w3.org/2001/XMLSchema#string

M H Lev

http://www.w3.org/2001/XMLSchema#string

R A Levy

http://www.w3.org/2001/XMLSchema#string

R Gilberto González

http://www.w3.org/2001/XMLSchema#string

S Pomerantz

http://www.w3.org/2001/XMLSchema#string

P2860

K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

Contrast-media-induced nephrotoxicity: a consensus report. Contrast Media Safety Committee, European Society of Urogenital Radiology (ESUR).

Hospital-acquired renal insufficiency.

Contrast-induced nephropathy: definition, epidemiology, and patients at risk.

Epidemiology and prognostic implications of contrast-induced nephropathy.

Epidemiology of contrast-induced nephropathy.

Pathophysiology of contrast medium-induced nephropathy.

Risk of nephropathy after intravenous administration of contrast material: a critical literature analysis.

Failure to demonstrate contrast nephrotoxicity.

P304

817-821

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3174/AJNR.A1927

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P50

Fabricio O Lima

P577

2009-12-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20044502

http://www.w3.org/2001/XMLSchema#string

P932

2873111

http://www.w3.org/2001/XMLSchema#string